Status:
COMPLETED
Cystic Fibrosis (CF) Flow Rates Study
Lead Sponsor:
Syntara
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
6-50 years
Brief Summary
We wish to measure the inspiratory flow and volumes generated by the subjects inhaling from a spirometer with a high resistance dry powder inhaler in series in subjects with cystic fibrosis.
Eligibility Criteria
Inclusion
- CF
- FEV1 ≥ 30% and \< 90% predicted
Exclusion
- Be considered "terminally ill" or listed for lung transplantation
- Have had a lung transplant
- Have had a significant episode of haemoptysis (\>60 ml) in the three months prior to enrolment
- Have had a myocardial infarction in the three months prior to enrolment
- Have had a cerebral vascular accident in the three months prior to enrolment
- Have had major ocular surgery in the three months prior to enrolment
- Have had major abdominal, chest or brain surgery in the three months prior to enrolment
- Have a known cerebral, aortic or abdominal aneurysm
- Be breast feeding or pregnant
- Be using beta blockers
- Have unstable asthma
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00779077
Start Date
January 1 2009
End Date
February 1 2009
Last Update
April 24 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.